Chapter 23. The Search for New Antibiotics

  1. Prof. Dr. Dr. h. c. mult. Jörg Hacker,
  2. Dr. Ulrich Dobrindt
  1. Harald Labischinski1,
  2. Christoph Freiberg2,
  3. Heike Brötz-Oesterhelt2

Published Online: 10 MAY 2006

DOI: 10.1002/352760801X.ch23

Pathogenomics: Genome Analysis of Pathogenic Microbes

Pathogenomics: Genome Analysis of Pathogenic Microbes

How to Cite

Labischinski, H., Freiberg, C. and Brötz-Oesterhelt, H. (2006) The Search for New Antibiotics, in Pathogenomics: Genome Analysis of Pathogenic Microbes (eds J. Hacker and U. Dobrindt), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/352760801X.ch23

Editor Information

  1. Universität Würzburg, Institut für Molekulare Infektionsbiologie, Röntgenring 11, 97070 Würzburg, Germany

Author Information

  1. 1

    Combinature Biopharm AG, Robert-Rössle-Str. 10, Gebäude 80, 13125 Berlin, Germany

  2. 2

    Bayer Healthcare AG, Pharma Research Center, Anti-Infective Research, Gebäude 405, 42096 Wuppertal, Germany

Publication History

  1. Published Online: 10 MAY 2006
  2. Published Print: 9 JAN 2006

ISBN Information

Print ISBN: 9783527312658

Online ISBN: 9783527608010

SEARCH

Keywords:

  • pathogenomics;
  • genomics of hosts;
  • search for new antibiotics;
  • need for novel antibiotics;
  • genomic technologies;
  • antibacterial research;
  • alternative approaches in antibacterial drug discovery;
  • targeting resistance mechanism;
  • extremely narrow-spectrum drugs;
  • phage therapies;
  • reducing virulence

Summary

This chapter contains sections titled:

  • The Need for Novel Antibiotics

  • Where Will the New Antibiotics Come From?

    • The Past

    • The Present

    • Future Directions

  • Contributions of Genomic Technologies to Antibacterial Research

    • Target Identification and Validation

    • Target Prioritization

    • Genetic Tools for Drug Screening and Mode-of-Action Determination

    • Genome-Wide Expression Profiling for Mode-of-Action Characterization

    • Outlook for Genomic Technologies for Antibiotic Drug Discovery

  • Alternative Approaches in Antibacterial Drug Discovery

    • Targeting the Resistance Mechanism

    • Extremely Narrow-Spectrum Drugs

    • Phage Therapies and other Bacteriolytic Approaches

    • Strategies for Reducing Virulence and/or Influencing Pathogenesis